AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC).

Katy Beckermann,Matthew T. Campbell,Naomi B. Haas,Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao,Hans J. Hammers,Saby George, Ariel Ann Nelson,Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad,Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller,Martin H. Voss,Brian I. Rini,Neil J. Shah

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览22
暂无评分
关键词
axl inhibitor,cabozantinib,batiraxcept,renal cell carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要